Cenduit Accelerates Technology Development, Aligns Operational Staff Closer to Customers as Global Biopharma Industry Champions Its Interactive Response Technology (IRT) System for Clinical Trials
Cenduit accelerates investments in technology; expands U.S. and international project management, service delivery and sales operations
Durham, NC – May 18, 2018 – Global IRT and e-Clinical solutions leader Cenduit LLC or ("the company") continued double-digit growth as pharma and biotech companies worldwide choose its market-leading IRT platform, featuring Quantum Interactive™ to help bring new drugs to patients through innovation, integration, quality and world-class services.
Cenduit CEO Sam Osman said, “Cenduit is experiencing accelerated growth as we continue our commitment to bringing quality, innovation and expertise to all of our clients. We’ve been doubling down on the hiring of both world-class PMs and delivery managers. Significant recent investments have also been made in a diversified leadership, new technology integration capabilities, process and service delivery model – backed by a veteran industry senior leadership team.”
To anchor its European-based operations, the company recently expanded outside of its Basel, Switzerland location, with a new collaboration center located in the heart of Nottingham, United Kingdom. This alignment is centered around a core belief in centralizing locations close to customers to better service their needs and collaborate on new solutions.
During Q1, Cenduit executives spanned the globe, speaking and demonstrating the company’s IRT platform at industry conferences including IRT Europe, Clinical Trial Supply Europe, and Outsourcing in Clinical Trials West Coast. Cenduit also recently announced its latest release of the Cenduit IRT platform and Quantum Interactive™.
CEO Sam Osman added, “After spending the majority of 2017 investing in people, processes and systems, Cenduit is enjoying significant growth into 2018 – laying the necessary infrastructure to execute flawlessly for the future. As more and more sponsors and CROs standardize on our IRT platform, the company is well-positioned for 2018 and beyond, with a world-class team committed to delivering better outcomes for patients throughout the eClinical solutions landscape.”
About Cenduit LLC
Cenduit enables clinical trial sponsors and CROs to safely, quickly and economically deliver new drugs and therapies to help save and improve lives. As the world leader in IRT systems, Cenduit offers customers consistently innovated rapid study startup software, clinical supply chain intelligence, clinical operations expertise and customer-centric CORE teams. With 500+ experts throughout the US, Europe and Asia, Cenduit helps customers manage clinical trials in over 100 countries, interacting with more than 800,000 patients at over 32,000 sites. Learn how Cenduit's experts can ensure your study needs are met on time and within budget. Visit www.cenduit.com for more information.
Contact:
Shannon L. Davies, Shannon.LappinDavies@cenduit.com +1 919-998-3393
Brenda Nashawaty, brenda@nashawaty.com +1 617-688-3253